
Sign up to save your podcasts
Or


In this episode Dr Davidsohn discusses taking RJB01 to trial with humans for a rare heart disease and how gene therapy is viewed by the FDA.
Dr Noah Davidsohn is a founder and Chief Scientific Officer of Rejuvenate Bio a company developing gene therapies to treat aging and age related diseases.
Rejuvenate Bio website
https://www.rejuvenatebio.com/
Dr Davidsohn's paper mentioned in the interview
A single combination gene therapy treats multiple age-related diseases
https://pubmed.ncbi.nlm.nih.gov/31685628/
NOVOS Core & NOVOS Boost https://novoslabs.com/?ref=3957 $5 off any purchase if users use code MODERN5
10% off DoNotAge all products with discount code MODERNHEALTHSPAN https://donotage.org/products/
10% Discount on Renue By Science products with code MHS https://renuebyscience.com/
ProHealth 10% of all products Code MODERN : https://www.prohealth.com/
By Modern Healthspan3.6
77 ratings
In this episode Dr Davidsohn discusses taking RJB01 to trial with humans for a rare heart disease and how gene therapy is viewed by the FDA.
Dr Noah Davidsohn is a founder and Chief Scientific Officer of Rejuvenate Bio a company developing gene therapies to treat aging and age related diseases.
Rejuvenate Bio website
https://www.rejuvenatebio.com/
Dr Davidsohn's paper mentioned in the interview
A single combination gene therapy treats multiple age-related diseases
https://pubmed.ncbi.nlm.nih.gov/31685628/
NOVOS Core & NOVOS Boost https://novoslabs.com/?ref=3957 $5 off any purchase if users use code MODERN5
10% off DoNotAge all products with discount code MODERNHEALTHSPAN https://donotage.org/products/
10% Discount on Renue By Science products with code MHS https://renuebyscience.com/
ProHealth 10% of all products Code MODERN : https://www.prohealth.com/

7,201 Listeners

5,003 Listeners

5,405 Listeners

294 Listeners

712 Listeners

4,886 Listeners

3,507 Listeners

9,209 Listeners

1,810 Listeners

1,099 Listeners

290 Listeners

233 Listeners

160 Listeners

184 Listeners

1,193 Listeners